APA (7th ed.) Citation

He X, Narushima K, Kojima M, Nagai C, & Li K. (2024). Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects. Dove Medical Press.

Chicago Style (17th ed.) Citation

He X, Narushima K, Kojima M, Nagai C, and Li K. Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects. Dove Medical Press, 2024.

MLA (9th ed.) Citation

He X, et al. Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects. Dove Medical Press, 2024.